IRONWOOD PHARMACEUTICALS INC
Company Stats
- Market Cap
- $656.0M
- as of Sep 30, 2026
- Shares Outstanding
- 165.2M
- Free Float
- 85.2%
Income Statement
- Revenue
- $296.2M
- Operating Income
- $98.5M
- Net Income
- $24.0M
- EBITDA
- $99.6M
- Revenue Growth, 3Y
- -10.3%
- FCF Margin, 3Y Avg
- 37.9%
- FCF Margin, Worst Year
- 29.4%
Cash Flow
- Free Cash Flow
- $127.0M
- FCF Yield
- 19.4%
- Owner FCF Yield
- 16.7%
Balance Sheet
- Cash & Equivalents
- $215.5M
Returns & Capital
- SBC, 3Y Avg
- $26.4M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $296.2M | $127.0M | 42.9% |
| FY2024 | $351.4M | $103.4M | 29.4% |
| FY2023 | $442.7M | $183.2M | 41.4% |
| FY2022 | $410.6M | $273.6M | 66.6% |
| FY2021 | $413.8M | $261.6M | 63.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 30, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back